How to Make Many Copies of a Specific DNA Segment
This patent describes the Polymerase Chain Reaction (PCR), a fundamental process for making millions of copies of a specific DNA or RNA segment from a tiny sample, enabling its detection.
Original patent title: “Process for amplifying, detecting, and/or-cloning nucleic acid sequences”
What this patent covers
The actual claim
This patent describes a process for detecting a specific nucleic acid sequence by repeatedly copying it. First, a sample containing nucleic acids is treated with two short DNA pieces called oligonucleotide primers, one for each strand of the target sequence, under conditions where they attach and an enzyme builds new complementary strands (Claim 1a). Next, the sample is heated to separate these newly formed strands from their templates (Claim 1b). The primers and enzyme then build new strands again using the separated strands as templates (Claim 1c). Repeating these steps (Claim 2) exponentially increases the amount of the specific nucleic acid. Finally, a labeled probe is added to bind to the amplified sequence, allowing its detection (Claim 1d, 1e). For example, this process could be used to find a specific viral DNA sequence in a patient sample.
What this patent does NOT cover
The boundaries
- Does not cover methods that amplify DNA without using two oligonucleotide primers, one for each strand of the target sequence.
- Does not cover methods that amplify DNA without repeating the denaturation and extension steps at least once.
- Does not cover methods for detecting a nucleic acid sequence that do not involve adding a labeled oligonucleotide probe and determining its hybridization.
- Does not cover amplification processes where the primers do not create extension products that can themselves serve as templates for the other primer.
- Does not cover methods that use enzymes not listed or functionally equivalent to those described in Claim 15 for polymerization.
These exclusions are unique to PatentBrief — derived from the actual claim language, not patent-office boilerplate.
What made this novel
The truly novel aspect was the idea of using a pair of primers and repeated cycles of denaturation, annealing, and extension to exponentially amplify a specific DNA segment, with each newly synthesized strand serving as a template for subsequent rounds.
Schematic visualization of the patent's claim structure. Hand-drawn diagrams in progress for each landmark patent.
Where you've seen this
Real-world examples
COVID-19 diagnostic tests
Forensic DNA analysis (e.g., crime scene investigation)
Paternity testing
Genetic disease screening (e.g., for sickle cell anemia as mentioned in Claim 12)
Detection of pathogenic organisms (e.g., bacteria, viruses)
Gene sequencing preparation
Why it matters
The bigger picture
This patent covers the Polymerase Chain Reaction (PCR), a technique that revolutionized molecular biology, medicine, and forensics. It made it possible to study tiny amounts of DNA, leading to breakthroughs in genetic research, disease diagnosis, and criminal investigations. PCR became an indispensable tool across countless scientific and commercial applications.
Filed
February 7, 1986
Granted
July 28, 1987
Market context
Who's building on this
Companies in this space
Companies like Thermo Fisher Scientific, Bio-Rad Laboratories, and Roche Diagnostics are major players in developing and selling PCR instruments, reagents, and kits. Illumina, a leader in DNA sequencing, also relies on PCR for sample preparation. Many startups and research institutions continue to innovate new applications and variations of PCR for diagnostics and research.
Market impact
The introduction of PCR created an entirely new market for molecular diagnostic tools and reagents. It enabled the rapid and sensitive detection of pathogens, genetic mutations, and individual genetic profiles, transforming fields from medicine to forensics. The patent led to significant licensing revenues for Cetus Corp and later Hoffmann-La Roche, and its expiration opened the door for even broader adoption and innovation in the technology.
Claim 1 — Plain English
What this patent covers
This patent describes a process for detecting a specific nucleic acid sequence by repeatedly copying it. First, a sample containing nucleic acids is treated with two short DNA pieces called oligonucleotide primers, one for each strand of the target sequence, under conditions where they attach and an enzyme builds new complementary strands (Claim 1a). Next, the sample is heated to separate these newly formed strands from their templates (Claim 1b). The primers and enzyme then build new strands again using the separated strands as templates (Claim 1c). Repeating these steps (Claim 2) exponentially increases the amount of the specific nucleic acid. Finally, a labeled probe is added to bind to the amplified sequence, allowing its detection (Claim 1d, 1e). For example, this process could be used to find a specific viral DNA sequence in a patient sample.
The clever bit
The truly novel aspect was the idea of using a pair of primers and repeated cycles of denaturation, annealing, and extension to exponentially amplify a specific DNA segment, with each newly synthesized strand serving as a template for subsequent rounds.
What it does not cover
- Does not cover methods that amplify DNA without using two oligonucleotide primers, one for each strand of the target sequence.
- Does not cover methods that amplify DNA without repeating the denaturation and extension steps at least once.
- Does not cover methods for detecting a nucleic acid sequence that do not involve adding a labeled oligonucleotide probe and determining its hybridization.
- Does not cover amplification processes where the primers do not create extension products that can themselves serve as templates for the other primer.
- Does not cover methods that use enzymes not listed or functionally equivalent to those described in Claim 15 for polymerization.
Patent Journey
From filing to expiry
Patent Filed
1986
Patent Granted
1987 · 1yr after filing
Highly Cited
6,227 patents cite this
Patent Expired
2006
PatentBrief Score
Impact Score
Strong
Citation count
40/40
Highly cited
Claim breadth
20/20
Very broad protection
Recency
0/20
Older than 20 years
Assignee scale
0/20
Independent or smaller assignee
PatentBrief Impact Score — based on citation count, claim breadth, recency, and assignee scale. Not a legal assessment.
The original legal language
Original claims
30 claims as filed with the patent office.
Citations
Patent lineage
Stay in the loop
Get a weekly digest of new patents.
One email per week. No spam. Unsubscribe anytime.
Keep exploring
Related patents you should know
US 12564871 · 2026
A Fixture for Cleaning Showerheads with Multiple Separate Chambers
This patent describes a cleaning device for showerheads that uses a fixture with three or more separate internal compartments and channels to direct cleaning fluid to the showerhead's upper surfaces.
ASM IP HOLDING BV
US 12324579 · 2025
Surgical Stapler Battery Health Check During Operation
This patent describes a powered surgical stapler that can detect if some of its rechargeable battery cells are damaged while it's actually firing staples, helping ensure the procedure finishes safely.
CILAG GMBH INT
US 12471982 · 2025
Surgical Tool That Combines Energy Treatment and Stapling
CILAG's patent details a surgical instrument that applies therapeutic energy to tissue, monitors its properties, then deploys staples, adapting the stapling based on the initial energy treatment and monitoring.
CILAG GMBH INT
US 11918209 · 2024
Real-Time Surgical Instrument Status on Live Video During Operations
This patent describes a surgical system that shows live video from inside the body and overlays important information about the surgical tool directly onto the screen, helping surgeons operate more precisely.
CILAG GMBH INT
US 8697359 · 2014
How to Use CRISPR-Cas9 to Edit Genes in Human Cells
This patent describes a method and system for precisely altering gene expression in eukaryotic cells, including human cells, using an engineered CRISPR-Cas9 system that targets and cleaves specific DNA sequences.
Massachusetts Institute of Technology
US 7657849 · 2010
How the iPhone's Slide-to-Unlock Gesture Worked
Apple's 2010 patent on unlocking a device by dragging a specific graphical image along a predefined path on a touchscreen, a gesture iconic with early iPhones.
Apple Inc
Semantically similar
You might also find these interesting
US 4237224 · 1980 · Leland Stanford Junior University
How to Make Hybrid DNA and Grow It in Microbes
US 8697359 · 2014 · Massachusetts Institute of Technology
How to Use CRISPR-Cas9 to Edit Genes in Human Cells
US 4405829 · 1983 · Massachusetts Institute of Technology
How RSA Public-Key Encryption Secures Digital Messages
US 3789832 · 1974
MRI — The Imaging Machine That Detects Cancer Without Radiation
Patent monitoring